跳至主要内容
临床试验/NL-OMON23958
NL-OMON23958
招募中
不适用

ongitudinal ultra-high field imaging in Parkinson’s Disease: Tracking the disease course.

In this project we work together with patients and their representatives, MHeNs School for Mental Health and Neuroscience, Maastricht University Medical Centre (MUMC+), BioBank Maastricht UMC+ and Scannexus.0 个研究点目标入组 190 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
In this project we work together with patients and their representatives, MHeNs School for Mental Health and Neuroscience, Maastricht University Medical Centre (MUMC+), BioBank Maastricht UMC+ and Scannexus.
入组人数
190
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Observational non invasive

研究者

发起方
In this project we work together with patients and their representatives, MHeNs School for Mental Health and Neuroscience, Maastricht University Medical Centre (MUMC+), BioBank Maastricht UMC+ and Scannexus.

入排标准

入选标准

  • Participants are eligible for participation in this study if they meet the following criteria:
  • 1\) All patients have to be diagnosed with PD by a neurologist, within the last 3 years before inclusion.
  • 2\) A score of \= 24 on the Montreal Cognitive Assessment (MoCA) at baseline.
  • 3\) Able to read and understand Dutch.
  • 4\) 18 years of age or older.
  • 5\) Providing written informed consent.

排除标准

  • 1\) Subjects with contra\-indications for a MRI scan, such as claustrophobia or subjects carrying incompatible metallic devices such as pacemakers and certain mechanical valves.
  • 2\) Advanced cognitive impairment (MoCA \<24\) or dementia according to the DSM V criteria at baseline.
  • 3\) Subjects with other neurodegenerative diseases.

结局指标

主要结局

未指定

相似试验